Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
11:00
TUAC0101
Long-term follow-up of PROUD: evidence for high continued HIV exposure and durable effectiveness of PrEP
Sheena McCormack, United Kingdom
Abstract
Slides
11:15
TUAC0102
On-demand PrEP with TDF/FTC remains highly effective among MSM with infrequent sexual intercourse: a sub-study of the ANRS IPERGAY trial
Guillemette Antoni, France
Abstract
PDF
11:30
TUAC0103
An open-label multiple dose phase 1 assessment of long-acting rilpivirine
Ian McGowan, United States
Abstract
Slides
11:45
TUAC0104
Impact of microbiota on female genital tissue and plasma concentrations of dapivirine
Sharon Hillier, United States
Abstract
Slides
12:00
TUAC0105
Experiences and perceptions of PrEP among gay and other men who sex with men (MSM) using PrEP in the PROUD study in England
Mitzy Gafos, United Kingdom
Abstract
Slides
12:15
TUAC0106LB
Safety, tolerability and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected women and men: HPTN 077
Raphael Landovitz, United States
Abstract
Slides